ENTITY
Eisai Co Ltd

Eisai Co Ltd (4523 JP)

114
Analysis
Health CareJapan
Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.
more
16 Nov 2017 06:26

Names Down in the First 11 Months Tend to Go up in Japan.....

We looked back over the last 16 years and found that names that are down in the first 11 months tend to outperform in December. To calculate the...

Logo
269 Views
Share
03 Nov 2017 08:49

Industrial Capsule: Pharmaceuticals in Japan

Industry’s growth facilitated by healthcare spending as Japan’s society agesThe revenue of Japanese pharmaceutical producers continued to grow in...

Share
09 Oct 2017 16:15

Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down

We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created...

21 Sep 2017 05:03

Large-Cap Names that Have Gotten a Lot More Volatile Recently....

We screened for large-cap names in Japan that have recently seen a spike in volatility. We calculated Beta over the last 6 months and compared it...

Logo
275 Views
Share
bearishDaiichi Sankyo
14 Sep 2017 07:49

Daiichi Sankyo (4568 JP) Releases Phase I Data for DS-8201 at ESMO 2017

Daiichi Sankyo [DSK] (4568 JP) released Phase I data for DS-8201 at ESMO 2017 as follows: 32% overall response rate, 82% disease control rate. The...

x